Published on 28 Jan 2024 on Insider Monkey via Yahoo Finance

Here’s Why Laughing Water Capital Sold Enzo Biochem Inc (ENZ)

Laughing Water Capital, an investment management company, released its fourth-quarter 2023 investor letter. A copy of the same can be downloaded here. In the fourth quarter, investment in the fund returned 3.2% bringing the yearly returns to 11.8%, net of all fees and expenses. The SP500TR and R2000 returned 11.7% and 14.0% during the quarter, respectively, bringing their year-to-date returns to 26.3% and 17.0%. In addition, you can check the top 5 holdings of the fund to know its best picks in 2023.

Laughing Water Capital featured stocks such as Enzo Biochem, Inc. (NYSE:ENZ) in the fourth quarter 2023 investor letter. Headquartered in Farmingdale, New York, Enzo Biochem, Inc. (NYSE:ENZ) is a diagnostics, clinical lab, and life sciences company. On January 29, 2024, Enzo Biochem, Inc. (NYSE:ENZ) stock closed at $1.27 per share. One-month return of Enzo Biochem, Inc. (NYSE:ENZ) was -15.33%, and its shares lost 5.22% of their value over the last 52 weeks. Enzo Biochem, Inc. (NYSE:ENZ) has a market capitalization of $64.122 million.

Laughing Water Capital stated the following regarding Enzo Biochem, Inc. (NYSE:ENZ) in its fourth quarter 2023 investor letter: